$57.51 +0.68 (%) Mylan Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio

    Benzinga | Dec. 18, 2014 | 04:31AM EST
  2. Teva Upgraded On Strength Of Copaxone MS Drug

    IBD | Dec. 12, 2014 | 10:38AM EST
  3. Mylan Launches First Generic Version Of Orapred ODT

    Benzinga | Dec. 11, 2014 | 07:04AM EST
  4. Merck-Cubist Deal Going Ahead Despite Patent Setback

    IBD | Dec. 9, 2014 | 11:27AM EST
  5. Two Gauges That Point To Fund Buying In A Stock

    IBD | Dec. 8, 2014 | 18:18PM EST
  6. Great Stocks In 2014: Airline, Video Game, Drugs Lead

    IBD | Dec. 4, 2014 | 18:53PM EST
  7. Medical Issues Keep Climbing Into Sell Zone

    IBD | Dec. 4, 2014 | 18:20PM EST
  8. Mylan Receives Tentative FDA Approval For Pediatric Formulations Of Abacavir/Lamivudine Through Innovative Collaboration With ViiV Healthcare And Clinton Health Access Initiative

    Benzinga | Dec. 4, 2014 | 10:01AM EST
  9. Weekly CFO Sells Highlight: Hospira Inc, Rockwood Holdings Inc, Mylan Inc.

    GuruFocus | Nov. 30, 2014 | 13:58PM EST
  10. CNBC's Stock Pops & Drops From November 26

    Benzinga | Nov. 28, 2014 | 07:01AM EST
  11. Stocks Mixed In Weak Volume; Mylan, Hain At New Highs

    IBD | Nov. 26, 2014 | 13:19PM EST
  12. Five Ethical Drugmakers Keep Leadership Positions

    IBD | Nov. 17, 2014 | 18:27PM EST
  13. Big Cap 20 Stuffed With Medical Names

    IBD | Nov. 10, 2014 | 19:34PM EST
  14. Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal

    IBD | Oct. 31, 2014 | 11:17AM EST
  15. Stocks Surge At Starting Bell; Mylan, Expedia, GoPro Rocket

    IBD | Oct. 31, 2014 | 10:36AM EST
  16. MYLAN

    IBD | Oct. 30, 2014 | 19:13PM EST
  17. Earnings Scheduled For October 30, 2014

    Benzinga | Oct. 30, 2014 | 05:12AM EST
  18. Biogen, Thermo Reports Disappoint; Abbott Accelerates

    IBD | Oct. 22, 2014 | 11:18AM EST
  19. Mylan Adjusts Pricing Terms Of Manufacturing Pacts With Abbot

    Benzinga | Oct. 22, 2014 | 07:24AM EST
  20. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  21. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  22. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD | Oct. 7, 2014 | 18:33PM EST
  23. Bank Of America Raises 2014 Outlook For Mylan Inc

    Benzinga | Oct. 6, 2014 | 07:22AM EST
  24. Mylan

    IBD | Oct. 3, 2014 | 18:44PM EST
  25. Jazz Pharmaceuticals Uses New Cash To Buy For Growth

    IBD | Oct. 3, 2014 | 14:39PM EST
  26. Stocks Open Higher On Jobs Data; Mylan, Salix, Mobileye Climb

    IBD | Oct. 3, 2014 | 10:39AM EST
  27. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 3, 2014 | 08:44AM EST
  28. Inversion Crackdown Leaves Several Deals In Limbo

    Benzinga | Sep. 23, 2014 | 12:41PM EST
  29. Gilead to license Sovaldi

    IBD | Sep. 15, 2014 | 18:53PM EST
  30. Gilead OKs Generic Sovaldi To Expand Global Access

    IBD | Sep. 15, 2014 | 11:35AM EST
  31. US Stock Futures Down Ahead Of Industrial Production Report

    Benzinga | Sep. 15, 2014 | 07:13AM EST
  32. Mylan In Pact With Gilead To Accelerate Access To Hepatitis C

    Benzinga | Sep. 15, 2014 | 06:31AM EST
  33. Corporate Tax Cuts Would Help Treasury And Investors

    IBD | Sep. 11, 2014 | 18:04PM EST
  34. Mylan to Acquire U.S. Rights to Arixtra Injection From Aspen

    Benzinga | Sep. 10, 2014 | 07:02AM EST
  35. Court Grants Summary Judgment In Favor Of Mylan And FDA Related To Generic

    Benzinga | Sep. 8, 2014 | 07:02AM EST
  36. Why Burger King Isn't Like Walgreen In Tax Inversions

    IBD | Aug. 25, 2014 | 13:23PM EST
  37. Benzinga's Top Downgrades

    Benzinga | Aug. 8, 2014 | 09:04AM EST
  38. US Stock Futures Edge Higher Ahead Of Productivity Data

    Benzinga | Aug. 8, 2014 | 07:41AM EST
  39. RBC Capital Downgrades Mylan To Sector Perform

    Benzinga | Aug. 8, 2014 | 07:10AM EST
  40. Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide

    IBD | Aug. 7, 2014 | 18:50PM EST
  41. Mylan shares down on Q2 miss

    IBD | Aug. 7, 2014 | 18:41PM EST
  42. S&P 500 Falls To Two-Month Low, Dow Drifts Further Away From The 17,000 Mark

    Benzinga | Aug. 7, 2014 | 16:41PM EST
  43. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD | Aug. 7, 2014 | 12:04PM EST
  44. US Stock Futures Rise; Jobless Claims Report In Focus

    Benzinga | Aug. 7, 2014 | 07:44AM EST
  45. UPDATE: Mylan Posts Lower Q2 Earnings, Narrows Full-Year Outlook

    Benzinga | Aug. 7, 2014 | 07:17AM EST
  46. Walgreen Seen Rejecting Tax Inversion Amid Pressure

    IBD | Aug. 5, 2014 | 15:26PM EST
  47. Walgreen Names New CFO Ahead of Possible Inversion

    IBD | Aug. 4, 2014 | 12:29PM EST
  48. 5 Drug Companies Profiting From Generics

    Benzinga | Aug. 4, 2014 | 08:29AM EST
  49. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD | Aug. 2, 2014 | 08:02AM EST
  50. How Obama Could End Walgreen's Tax-Inversion Hopes

    IBD | Jul. 28, 2014 | 14:41PM EST
Trading Center